Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 75 | 2024 | 9742 | 3.300 |
Why?
|
Cerebral Angiography | 33 | 2019 | 1274 | 3.190 |
Why?
|
Diffusion Magnetic Resonance Imaging | 39 | 2024 | 2820 | 2.680 |
Why?
|
Brain Ischemia | 35 | 2024 | 3008 | 2.310 |
Why?
|
Magnetic Resonance Angiography | 18 | 2019 | 1434 | 1.830 |
Why?
|
Cerebral Infarction | 20 | 2020 | 975 | 1.610 |
Why?
|
Tomography, X-Ray Computed | 58 | 2023 | 20766 | 1.380 |
Why?
|
Magnetic Resonance Imaging | 100 | 2024 | 36849 | 1.360 |
Why?
|
Radiology | 13 | 2024 | 2117 | 1.360 |
Why?
|
Brain | 82 | 2024 | 27452 | 1.350 |
Why?
|
Cerebral Arteries | 8 | 2018 | 489 | 1.030 |
Why?
|
Diagnostic Imaging | 9 | 2021 | 3541 | 1.010 |
Why?
|
Infarction | 3 | 2024 | 246 | 0.980 |
Why?
|
Cerebrovascular Disorders | 11 | 2019 | 1486 | 0.790 |
Why?
|
Triage | 6 | 2021 | 994 | 0.790 |
Why?
|
Brain Diseases | 8 | 2024 | 1552 | 0.780 |
Why?
|
Thrombolytic Therapy | 11 | 2021 | 2050 | 0.760 |
Why?
|
Cerebral Revascularization | 3 | 2013 | 263 | 0.720 |
Why?
|
Cerebrovascular Circulation | 21 | 2017 | 2736 | 0.660 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2019 | 68 | 0.640 |
Why?
|
Vascular Diseases | 3 | 2019 | 1161 | 0.620 |
Why?
|
Neuroradiography | 4 | 2016 | 71 | 0.590 |
Why?
|
Central Nervous System Diseases | 3 | 2019 | 523 | 0.570 |
Why?
|
Ischemic Attack, Transient | 8 | 2013 | 877 | 0.560 |
Why?
|
Tuberculosis, Meningeal | 2 | 2014 | 49 | 0.560 |
Why?
|
Perfusion Imaging | 6 | 2015 | 196 | 0.560 |
Why?
|
Reperfusion | 4 | 2014 | 266 | 0.550 |
Why?
|
Leadership | 3 | 2024 | 1395 | 0.520 |
Why?
|
Internship and Residency | 6 | 2023 | 5948 | 0.510 |
Why?
|
Impulsive Behavior | 1 | 2018 | 349 | 0.500 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 266 | 0.500 |
Why?
|
Meninges | 1 | 2017 | 197 | 0.490 |
Why?
|
Echo-Planar Imaging | 6 | 2022 | 669 | 0.490 |
Why?
|
Head Injuries, Closed | 3 | 2010 | 133 | 0.490 |
Why?
|
Cerebral Hemorrhage | 14 | 2011 | 2653 | 0.490 |
Why?
|
Intracranial Hemorrhages | 5 | 2023 | 811 | 0.490 |
Why?
|
Gadolinium | 8 | 2021 | 965 | 0.470 |
Why?
|
Humans | 238 | 2024 | 768298 | 0.460 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1664 | 0.460 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2020 | 3411 | 0.450 |
Why?
|
Frontal Lobe | 2 | 2018 | 1428 | 0.410 |
Why?
|
Diagnosis, Differential | 34 | 2024 | 13019 | 0.410 |
Why?
|
Glioblastoma | 5 | 2014 | 3526 | 0.400 |
Why?
|
Aged | 117 | 2024 | 171544 | 0.400 |
Why?
|
Radiology Department, Hospital | 3 | 2021 | 409 | 0.400 |
Why?
|
Burnout, Professional | 1 | 2021 | 712 | 0.400 |
Why?
|
Confusion | 6 | 2022 | 278 | 0.400 |
Why?
|
Aneurysm, Ruptured | 2 | 2015 | 462 | 0.390 |
Why?
|
Contrast Media | 18 | 2017 | 5337 | 0.380 |
Why?
|
Diffuse Axonal Injury | 4 | 2004 | 49 | 0.370 |
Why?
|
Brain Neoplasms | 13 | 2017 | 9197 | 0.360 |
Why?
|
Aged, 80 and over | 69 | 2024 | 59683 | 0.360 |
Why?
|
Intraoperative Care | 1 | 2014 | 771 | 0.350 |
Why?
|
Carotid Stenosis | 4 | 2012 | 862 | 0.340 |
Why?
|
Middle Aged | 111 | 2024 | 223463 | 0.340 |
Why?
|
Coma | 3 | 2023 | 487 | 0.340 |
Why?
|
Male | 138 | 2024 | 364870 | 0.340 |
Why?
|
Sinus Thrombosis, Intracranial | 3 | 2010 | 110 | 0.330 |
Why?
|
Executive Function | 1 | 2018 | 1405 | 0.330 |
Why?
|
Sensitivity and Specificity | 28 | 2017 | 14736 | 0.330 |
Why?
|
Image Processing, Computer-Assisted | 18 | 2024 | 9063 | 0.320 |
Why?
|
Algorithms | 11 | 2023 | 14154 | 0.310 |
Why?
|
Acute Disease | 20 | 2017 | 7242 | 0.310 |
Why?
|
Meningeal Neoplasms | 3 | 2014 | 1253 | 0.310 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 221 | 0.300 |
Why?
|
Headache | 4 | 2022 | 1262 | 0.300 |
Why?
|
Education, Medical, Graduate | 4 | 2023 | 2411 | 0.300 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.300 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 113 | 0.290 |
Why?
|
Intracranial Aneurysm | 2 | 2015 | 1293 | 0.280 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1397 | 0.280 |
Why?
|
Female | 131 | 2024 | 397050 | 0.280 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2257 | 0.280 |
Why?
|
Glasgow Coma Scale | 4 | 2022 | 580 | 0.280 |
Why?
|
Image Enhancement | 8 | 2016 | 2894 | 0.270 |
Why?
|
Patient Selection | 6 | 2017 | 4265 | 0.260 |
Why?
|
Brain Infarction | 4 | 2012 | 288 | 0.260 |
Why?
|
Reproducibility of Results | 26 | 2020 | 20224 | 0.260 |
Why?
|
Brain Edema | 3 | 2022 | 607 | 0.260 |
Why?
|
Radiology Information Systems | 3 | 2020 | 533 | 0.250 |
Why?
|
Health Expenditures | 2 | 2015 | 2395 | 0.250 |
Why?
|
Thrombectomy | 3 | 2021 | 671 | 0.250 |
Why?
|
Consciousness Disorders | 2 | 2021 | 445 | 0.240 |
Why?
|
Accidental Falls | 2 | 2024 | 1080 | 0.240 |
Why?
|
Radiography | 11 | 2023 | 6993 | 0.240 |
Why?
|
Basilar Artery | 3 | 2017 | 207 | 0.240 |
Why?
|
Webcasts as Topic | 1 | 2024 | 21 | 0.230 |
Why?
|
Severity of Illness Index | 14 | 2021 | 15939 | 0.230 |
Why?
|
Neck Injuries | 2 | 2010 | 162 | 0.230 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 274 | 0.230 |
Why?
|
Stiff-Person Syndrome | 1 | 2024 | 31 | 0.230 |
Why?
|
Fibrinolytic Agents | 2 | 2012 | 2073 | 0.230 |
Why?
|
Retrospective Studies | 39 | 2023 | 81768 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2011 | 1226 | 0.220 |
Why?
|
Artifacts | 9 | 2023 | 1930 | 0.220 |
Why?
|
Muscle Weakness | 4 | 2022 | 415 | 0.220 |
Why?
|
Angiography | 2 | 2009 | 1597 | 0.220 |
Why?
|
Perfusion | 6 | 2021 | 1402 | 0.220 |
Why?
|
Diffusion | 10 | 2011 | 818 | 0.220 |
Why?
|
Functional Laterality | 1 | 2010 | 2268 | 0.210 |
Why?
|
Personnel Selection | 1 | 2005 | 201 | 0.210 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1946 | 0.210 |
Why?
|
Fatal Outcome | 10 | 2022 | 1837 | 0.210 |
Why?
|
Eclampsia | 2 | 2009 | 60 | 0.210 |
Why?
|
Blood Volume | 4 | 2012 | 545 | 0.210 |
Why?
|
Glioma | 3 | 2014 | 3526 | 0.210 |
Why?
|
Adult | 83 | 2024 | 223622 | 0.210 |
Why?
|
Health Policy | 1 | 2015 | 2698 | 0.210 |
Why?
|
Tissue Survival | 1 | 2003 | 120 | 0.210 |
Why?
|
Predictive Value of Tests | 15 | 2015 | 15455 | 0.200 |
Why?
|
West Nile Fever | 2 | 2017 | 77 | 0.200 |
Why?
|
Meningoencephalitis | 2 | 2018 | 83 | 0.200 |
Why?
|
Neuroschistosomiasis | 1 | 2001 | 3 | 0.200 |
Why?
|
Critical Care | 1 | 2015 | 2716 | 0.200 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1375 | 0.200 |
Why?
|
Artificial Intelligence | 3 | 2021 | 2661 | 0.200 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1885 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 4 | 2023 | 4076 | 0.190 |
Why?
|
Inpatients | 2 | 2024 | 2569 | 0.190 |
Why?
|
Spin Labels | 2 | 2021 | 339 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 3 | 2018 | 746 | 0.190 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 495 | 0.190 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 92 | 0.190 |
Why?
|
Bipolar Disorder | 1 | 2018 | 5126 | 0.180 |
Why?
|
Relapsing Fever | 1 | 2020 | 25 | 0.180 |
Why?
|
Leukoencephalopathies | 2 | 2021 | 260 | 0.180 |
Why?
|
Borrelia | 1 | 2020 | 66 | 0.180 |
Why?
|
Mycobacterium bovis | 1 | 2021 | 148 | 0.180 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2012 | 485 | 0.170 |
Why?
|
Prognosis | 17 | 2023 | 30020 | 0.170 |
Why?
|
Back Pain | 1 | 2024 | 547 | 0.170 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5830 | 0.170 |
Why?
|
Carotid Arteries | 2 | 2018 | 943 | 0.170 |
Why?
|
Angiography, Digital Subtraction | 2 | 2019 | 332 | 0.170 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 45 | 0.160 |
Why?
|
ROC Curve | 6 | 2014 | 3622 | 0.160 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 809 | 0.160 |
Why?
|
Diagnostic Errors | 3 | 2015 | 1280 | 0.160 |
Why?
|
Academic Medical Centers | 5 | 2021 | 2783 | 0.160 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1469 | 0.160 |
Why?
|
Fever | 4 | 2022 | 1620 | 0.160 |
Why?
|
Carcinoma | 2 | 2007 | 2340 | 0.160 |
Why?
|
Comparative Effectiveness Research | 2 | 2014 | 712 | 0.160 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2014 | 794 | 0.160 |
Why?
|
Collateral Circulation | 2 | 2017 | 291 | 0.150 |
Why?
|
Brain Injuries | 5 | 2021 | 2059 | 0.150 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7453 | 0.150 |
Why?
|
Disability Evaluation | 2 | 2009 | 1838 | 0.150 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 138 | 0.150 |
Why?
|
Persistent Vegetative State | 1 | 2020 | 275 | 0.150 |
Why?
|
Night Care | 1 | 2017 | 28 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 340 | 0.140 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 50 | 0.140 |
Why?
|
Carotid Artery, Internal | 4 | 2015 | 445 | 0.140 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 98 | 0.140 |
Why?
|
Septins | 1 | 2016 | 49 | 0.140 |
Why?
|
Hemorrhage | 1 | 2009 | 3461 | 0.140 |
Why?
|
Microvessels | 1 | 2021 | 586 | 0.130 |
Why?
|
Software | 2 | 2009 | 4452 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2020 | 603 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2518 | 0.130 |
Why?
|
Blood Volume Determination | 2 | 2012 | 41 | 0.130 |
Why?
|
Recovery of Function | 3 | 2021 | 2990 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39405 | 0.130 |
Why?
|
Lumbosacral Region | 1 | 2017 | 294 | 0.130 |
Why?
|
Purpura | 1 | 1996 | 117 | 0.130 |
Why?
|
Encephalomyelitis, Eastern Equine | 2 | 2008 | 14 | 0.120 |
Why?
|
Regional Blood Flow | 4 | 2008 | 1502 | 0.120 |
Why?
|
Compensation and Redress | 1 | 2015 | 66 | 0.120 |
Why?
|
Hepatic Encephalopathy | 1 | 2016 | 144 | 0.120 |
Why?
|
Injections, Intra-Arterial | 2 | 2006 | 181 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 3 | 2013 | 1163 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2015 | 273 | 0.120 |
Why?
|
Astrocytoma | 2 | 2013 | 780 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2010 | 417 | 0.120 |
Why?
|
Brain Stem | 3 | 2014 | 862 | 0.120 |
Why?
|
Subarachnoid Hemorrhage | 2 | 1999 | 1039 | 0.120 |
Why?
|
Neck | 1 | 2019 | 736 | 0.120 |
Why?
|
Biliary Tract Neoplasms | 1 | 2016 | 187 | 0.120 |
Why?
|
Medulla Oblongata | 1 | 2016 | 248 | 0.120 |
Why?
|
Gadolinium DTPA | 2 | 2011 | 823 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 182 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 2862 | 0.120 |
Why?
|
Motion | 3 | 2023 | 789 | 0.120 |
Why?
|
Renal Insufficiency | 3 | 2021 | 809 | 0.120 |
Why?
|
Efficiency | 1 | 2017 | 477 | 0.110 |
Why?
|
Endovascular Procedures | 3 | 2021 | 2215 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2020 | 1218 | 0.110 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2014 | 1189 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2014 | 197 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 997 | 0.110 |
Why?
|
Fellowships and Scholarships | 3 | 2016 | 1133 | 0.110 |
Why?
|
Paresis | 2 | 2012 | 177 | 0.110 |
Why?
|
Tomography | 1 | 1996 | 442 | 0.110 |
Why?
|
Personality Disorders | 1 | 2018 | 729 | 0.110 |
Why?
|
Head | 1 | 2019 | 927 | 0.110 |
Why?
|
Governing Board | 1 | 2013 | 50 | 0.110 |
Why?
|
Heart Arrest | 1 | 2023 | 1516 | 0.110 |
Why?
|
Hyperplasia | 2 | 2013 | 1152 | 0.110 |
Why?
|
Alcohol Withdrawal Seizures | 1 | 2012 | 10 | 0.110 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2013 | 88 | 0.110 |
Why?
|
Leukoaraiosis | 2 | 2019 | 115 | 0.100 |
Why?
|
United States | 15 | 2021 | 73144 | 0.100 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2012 | 26 | 0.100 |
Why?
|
Peer Review | 1 | 2015 | 219 | 0.100 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 128 | 0.100 |
Why?
|
Time Factors | 17 | 2017 | 40267 | 0.100 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 1999 | 892 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.100 |
Why?
|
Adolescent | 26 | 2020 | 89182 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2018 | 863 | 0.100 |
Why?
|
Pituitary Neoplasms | 2 | 2011 | 1325 | 0.100 |
Why?
|
Treatment Outcome | 18 | 2017 | 65365 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2014 | 1585 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.100 |
Why?
|
Cerebrospinal Fluid | 3 | 2020 | 545 | 0.100 |
Why?
|
Vascular Neoplasms | 1 | 2013 | 167 | 0.100 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2013 | 142 | 0.100 |
Why?
|
Nelson Syndrome | 1 | 2011 | 20 | 0.100 |
Why?
|
Risk Factors | 14 | 2023 | 74954 | 0.100 |
Why?
|
West Nile virus | 2 | 2017 | 77 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1817 | 0.100 |
Why?
|
Adrenal Cortex | 1 | 2011 | 134 | 0.090 |
Why?
|
Young Adult | 15 | 2023 | 60048 | 0.090 |
Why?
|
Critical Pathways | 1 | 2015 | 476 | 0.090 |
Why?
|
Artificial Limbs | 1 | 2012 | 121 | 0.090 |
Why?
|
Magnetics | 1 | 2014 | 599 | 0.090 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2011 | 101 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1094 | 0.090 |
Why?
|
Patient Discharge | 1 | 2004 | 3474 | 0.090 |
Why?
|
Iopamidol | 1 | 2011 | 187 | 0.090 |
Why?
|
Observer Variation | 6 | 2012 | 2623 | 0.090 |
Why?
|
Hepatitis B | 1 | 2016 | 707 | 0.090 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2011 | 1077 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 561 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2021 | 3800 | 0.090 |
Why?
|
Adenoma | 2 | 2011 | 2163 | 0.090 |
Why?
|
Radiation Injuries | 2 | 2010 | 1204 | 0.090 |
Why?
|
Ultrasonography | 3 | 2019 | 6001 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2012 | 369 | 0.080 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.080 |
Why?
|
Child | 17 | 2019 | 80894 | 0.080 |
Why?
|
Cerebral Veins | 1 | 2011 | 158 | 0.080 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2009 | 30 | 0.080 |
Why?
|
Meglumine | 1 | 2009 | 144 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 391 | 0.080 |
Why?
|
Advisory Committees | 1 | 2013 | 797 | 0.080 |
Why?
|
Adrenal Glands | 1 | 2011 | 557 | 0.080 |
Why?
|
Medicare | 4 | 2015 | 6881 | 0.080 |
Why?
|
Radiology, Interventional | 1 | 2013 | 483 | 0.080 |
Why?
|
Health Promotion | 1 | 2021 | 2209 | 0.080 |
Why?
|
Phlebography | 1 | 2010 | 326 | 0.080 |
Why?
|
Cerebellar Neoplasms | 1 | 2013 | 590 | 0.080 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2008 | 12 | 0.080 |
Why?
|
Skull Fractures | 1 | 2010 | 203 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 807 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1943 | 0.080 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 479 | 0.070 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6404 | 0.070 |
Why?
|
Tuberculosis | 1 | 2021 | 2029 | 0.070 |
Why?
|
Statistics as Topic | 3 | 2012 | 2363 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3781 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2429 | 0.070 |
Why?
|
Acromegaly | 1 | 2010 | 316 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2012 | 819 | 0.070 |
Why?
|
Lyme Neuroborreliosis | 1 | 2007 | 50 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3912 | 0.070 |
Why?
|
Extremities | 1 | 2012 | 870 | 0.070 |
Why?
|
Prospective Studies | 13 | 2024 | 54921 | 0.070 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 214 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2011 | 5367 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 3247 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2009 | 648 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2913 | 0.060 |
Why?
|
Pandemics | 3 | 2021 | 8750 | 0.060 |
Why?
|
Puerperal Disorders | 1 | 2009 | 303 | 0.060 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2005 | 24 | 0.060 |
Why?
|
Borrelia burgdorferi | 1 | 2007 | 183 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 786 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 648 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 1335 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 385 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8051 | 0.060 |
Why?
|
Iohexol | 1 | 2006 | 205 | 0.060 |
Why?
|
Seizures | 4 | 2012 | 3000 | 0.060 |
Why?
|
Child, Preschool | 9 | 2019 | 42654 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12092 | 0.060 |
Why?
|
Meningioma | 2 | 2012 | 1221 | 0.060 |
Why?
|
Aneurysm | 1 | 2007 | 343 | 0.060 |
Why?
|
Hypertension | 4 | 2019 | 8615 | 0.060 |
Why?
|
Patient Admission | 1 | 2011 | 1367 | 0.060 |
Why?
|
Infertility, Female | 1 | 2010 | 765 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 123 | 0.060 |
Why?
|
Health Care Reform | 1 | 2013 | 1262 | 0.060 |
Why?
|
Spasm | 1 | 2024 | 131 | 0.060 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7955 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2011 | 1841 | 0.050 |
Why?
|
Encephalitis | 2 | 2017 | 441 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 267 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8747 | 0.050 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2004 | 99 | 0.050 |
Why?
|
Body Water | 1 | 2004 | 340 | 0.050 |
Why?
|
Thalamus | 2 | 2000 | 1050 | 0.050 |
Why?
|
Corpus Callosum | 2 | 2005 | 754 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2005 | 11854 | 0.050 |
Why?
|
Cohort Studies | 9 | 2016 | 41791 | 0.050 |
Why?
|
Videoconferencing | 1 | 2004 | 209 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2014 | 3838 | 0.050 |
Why?
|
Deoxycytidine | 2 | 2005 | 887 | 0.050 |
Why?
|
Time | 1 | 2024 | 546 | 0.050 |
Why?
|
Oligodendroglioma | 1 | 2004 | 278 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3236 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2720 | 0.050 |
Why?
|
Remote Consultation | 1 | 2004 | 242 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2024 | 449 | 0.050 |
Why?
|
Orbital Neoplasms | 1 | 2004 | 223 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2014 | 3942 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2012 | 9433 | 0.050 |
Why?
|
Amnesia, Transient Global | 1 | 2001 | 19 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16716 | 0.050 |
Why?
|
Biopsy | 4 | 2019 | 6808 | 0.050 |
Why?
|
Boronic Acids | 1 | 2005 | 915 | 0.050 |
Why?
|
Documentation | 1 | 2007 | 917 | 0.050 |
Why?
|
Burns | 1 | 2012 | 1893 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3520 | 0.050 |
Why?
|
Comorbidity | 6 | 2012 | 10588 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2056 | 0.050 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 118 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1445 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2024 | 2487 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3707 | 0.050 |
Why?
|
Spinal Stenosis | 1 | 2024 | 261 | 0.040 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1643 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6670 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 549 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2002 | 962 | 0.040 |
Why?
|
Subarachnoid Space | 1 | 1999 | 79 | 0.040 |
Why?
|
Medicaid | 1 | 2013 | 2842 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5711 | 0.040 |
Why?
|
Survival Rate | 3 | 2009 | 12870 | 0.040 |
Why?
|
Speech Disorders | 1 | 2020 | 180 | 0.040 |
Why?
|
Pyrazines | 1 | 2005 | 1206 | 0.040 |
Why?
|
Syndrome | 2 | 2009 | 3275 | 0.040 |
Why?
|
Metabolic Clearance Rate | 1 | 1999 | 363 | 0.040 |
Why?
|
Relative Value Scales | 1 | 2019 | 86 | 0.040 |
Why?
|
Leg | 1 | 2024 | 1088 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1413 | 0.040 |
Why?
|
Pilot Projects | 5 | 2012 | 8730 | 0.040 |
Why?
|
Career Choice | 1 | 2005 | 769 | 0.040 |
Why?
|
Spinal Diseases | 1 | 2024 | 563 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2000 | 376 | 0.040 |
Why?
|
Massachusetts | 4 | 2013 | 8902 | 0.040 |
Why?
|
Craniotomy | 2 | 2014 | 747 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2708 | 0.040 |
Why?
|
Intracranial Embolism | 1 | 2000 | 189 | 0.040 |
Why?
|
Mutism | 1 | 1998 | 27 | 0.040 |
Why?
|
Foscarnet | 1 | 2018 | 36 | 0.040 |
Why?
|
Aneurysm, False | 1 | 2021 | 263 | 0.040 |
Why?
|
Disease Progression | 7 | 2014 | 13646 | 0.040 |
Why?
|
Graft vs Host Reaction | 1 | 2018 | 99 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 284 | 0.040 |
Why?
|
Shock | 1 | 2020 | 316 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 759 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2022 | 634 | 0.040 |
Why?
|
Intracranial Hypotension | 1 | 1998 | 42 | 0.040 |
Why?
|
Time and Motion Studies | 1 | 2017 | 143 | 0.040 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2009 | 953 | 0.040 |
Why?
|
Security Measures | 1 | 2017 | 83 | 0.030 |
Why?
|
Animals | 5 | 2017 | 169322 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2020 | 540 | 0.030 |
Why?
|
Decerebrate State | 1 | 2016 | 42 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2008 | 3211 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3921 | 0.030 |
Why?
|
Calcinosis | 2 | 2009 | 1482 | 0.030 |
Why?
|
Schistosomiasis mansoni | 1 | 1997 | 94 | 0.030 |
Why?
|
Prevalence | 5 | 2012 | 15868 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2001 | 671 | 0.030 |
Why?
|
Plasmacytoma | 1 | 1997 | 170 | 0.030 |
Why?
|
Area Under Curve | 2 | 2011 | 1642 | 0.030 |
Why?
|
Dura Mater | 1 | 1998 | 297 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1727 | 0.030 |
Why?
|
Hepatitis, Viral, Human | 1 | 2016 | 141 | 0.030 |
Why?
|
Circle of Willis | 1 | 2015 | 77 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 1998 | 1998 | 0.030 |
Why?
|
Oxygen | 2 | 2024 | 4273 | 0.030 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 50 | 0.030 |
Why?
|
Infant | 7 | 2019 | 36512 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1033 | 0.030 |
Why?
|
Curriculum | 2 | 2021 | 3775 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 1995 | 72 | 0.030 |
Why?
|
Olfaction Disorders | 1 | 1997 | 226 | 0.030 |
Why?
|
DiGeorge Syndrome | 1 | 1996 | 187 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2021 | 742 | 0.030 |
Why?
|
Causality | 2 | 2012 | 1255 | 0.030 |
Why?
|
Medicare Payment Advisory Commission | 1 | 2014 | 14 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 525 | 0.030 |
Why?
|
Gallbladder | 1 | 2016 | 308 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 823 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3438 | 0.030 |
Why?
|
Dapsone | 1 | 1994 | 55 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 904 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2528 | 0.030 |
Why?
|
Gastric Acid | 1 | 1994 | 99 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1112 | 0.030 |
Why?
|
Antacids | 1 | 1994 | 94 | 0.030 |
Why?
|
Unconsciousness | 1 | 2016 | 251 | 0.030 |
Why?
|
Thalamic Diseases | 1 | 2013 | 15 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2012 | 2226 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1013 | 0.030 |
Why?
|
Liability, Legal | 1 | 2015 | 208 | 0.030 |
Why?
|
Telephone | 1 | 2017 | 630 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1142 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6209 | 0.030 |
Why?
|
Management Audit | 1 | 2013 | 23 | 0.030 |
Why?
|
Encephalitis, Viral | 1 | 2013 | 59 | 0.030 |
Why?
|
Electroencephalography | 3 | 2020 | 6317 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1603 | 0.030 |
Why?
|
Necrosis | 2 | 2010 | 1619 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1994 | 400 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1555 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9371 | 0.030 |
Why?
|
Writing | 1 | 2015 | 200 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2005 | 5443 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1219 | 0.030 |
Why?
|
Vasodilation | 1 | 1997 | 968 | 0.030 |
Why?
|
Government Agencies | 1 | 2013 | 161 | 0.030 |
Why?
|
Prisoners | 1 | 2016 | 315 | 0.030 |
Why?
|
Epirubicin | 2 | 2003 | 81 | 0.030 |
Why?
|
Smoke Inhalation Injury | 1 | 2012 | 47 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1728 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5857 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2877 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2007 | 21163 | 0.030 |
Why?
|
Diplopia | 1 | 2014 | 217 | 0.030 |
Why?
|
Alberta | 1 | 2012 | 67 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2000 | 1031 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1997 | 534 | 0.020 |
Why?
|
Hypercalcemia | 1 | 1995 | 423 | 0.020 |
Why?
|
Hippocampus | 1 | 2024 | 3784 | 0.020 |
Why?
|
Risk Assessment | 5 | 2012 | 24316 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 509 | 0.020 |
Why?
|
Mitral Valve | 1 | 2000 | 1474 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2005 | 1378 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 627 | 0.020 |
Why?
|
Family | 1 | 2022 | 3208 | 0.020 |
Why?
|
Hysterosalpingography | 1 | 2010 | 26 | 0.020 |
Why?
|
Adrenal Gland Diseases | 1 | 2011 | 141 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15854 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 478 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Oligomenorrhea | 1 | 2010 | 42 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1996 | 790 | 0.020 |
Why?
|
Anisotropy | 2 | 2004 | 1296 | 0.020 |
Why?
|
Vision Disorders | 1 | 1997 | 1093 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2012 | 559 | 0.020 |
Why?
|
Movement | 1 | 2017 | 1490 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2012 | 307 | 0.020 |
Why?
|
Radiotherapy | 2 | 2010 | 1509 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2013 | 435 | 0.020 |
Why?
|
Spinal Cord | 2 | 2011 | 1813 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10087 | 0.020 |
Why?
|
Putamen | 1 | 2011 | 293 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 619 | 0.020 |
Why?
|
Sella Turcica | 1 | 2010 | 117 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2011 | 348 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1642 | 0.020 |
Why?
|
Washington | 1 | 2010 | 314 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2011 | 392 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 1972 | 394 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3121 | 0.020 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2011 | 179 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2010 | 324 | 0.020 |
Why?
|
Neurosurgery | 1 | 2016 | 690 | 0.020 |
Why?
|
Computers | 1 | 1972 | 592 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4834 | 0.020 |
Why?
|
Delirium | 1 | 2021 | 1695 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2016 | 894 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2721 | 0.020 |
Why?
|
Jugular Veins | 1 | 2010 | 211 | 0.020 |
Why?
|
Headache Disorders, Primary | 1 | 2009 | 39 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2529 | 0.020 |
Why?
|
Disease Vectors | 1 | 2008 | 61 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2139 | 0.020 |
Why?
|
Thymoma | 1 | 1990 | 191 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3631 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2426 | 0.020 |
Why?
|
Health Services | 1 | 1993 | 756 | 0.020 |
Why?
|
Endometrium | 1 | 2010 | 407 | 0.020 |
Why?
|
Thymus Neoplasms | 1 | 1990 | 277 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1092 | 0.020 |
Why?
|
Fluorouracil | 2 | 2003 | 1655 | 0.020 |
Why?
|
Myasthenia Gravis | 1 | 1990 | 217 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1548 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 877 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2010 | 346 | 0.020 |
Why?
|
Cyclophosphamide | 2 | 2003 | 2226 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 2007 | 111 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2009 | 594 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6740 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2715 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13323 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 383 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 1967 | 183 | 0.020 |
Why?
|
Bacterial Infections | 2 | 2008 | 1397 | 0.020 |
Why?
|
Paralysis | 1 | 2007 | 250 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2001 | 26410 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2126 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 3064 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5800 | 0.020 |
Why?
|
Reference Standards | 1 | 2009 | 1013 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14783 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2734 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2923 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 577 | 0.020 |
Why?
|
Hemodynamics | 1 | 2014 | 4199 | 0.010 |
Why?
|
Attitude to Health | 1 | 1993 | 2025 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1410 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 878 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1528 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1972 | 1207 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3826 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.010 |
Why?
|
Hyperoxia | 1 | 2005 | 261 | 0.010 |
Why?
|
Blood Pressure | 1 | 1998 | 8541 | 0.010 |
Why?
|
Postoperative Period | 1 | 2007 | 1830 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 624 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4419 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13696 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1629 | 0.010 |
Why?
|
Virus Diseases | 1 | 2008 | 723 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1140 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2060 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 21544 | 0.010 |
Why?
|
Survival Analysis | 2 | 2005 | 10117 | 0.010 |
Why?
|
Alcoholism | 1 | 2012 | 1981 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3960 | 0.010 |
Why?
|
Pregnancy | 2 | 2009 | 30198 | 0.010 |
Why?
|
Aging | 2 | 2008 | 8764 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2812 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8378 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2005 | 1605 | 0.010 |
Why?
|
Cough | 1 | 2005 | 599 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6238 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2005 | 992 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 2097 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1478 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18472 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 31 | 0.010 |
Why?
|
Central Nervous System | 1 | 2007 | 1346 | 0.010 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2007 | 1180 | 0.010 |
Why?
|
Decision Making | 1 | 1993 | 3953 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1993 | 3230 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10377 | 0.010 |
Why?
|
Subdural Effusion | 1 | 1998 | 19 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11117 | 0.010 |
Why?
|
Indium Radioisotopes | 1 | 1998 | 116 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2931 | 0.010 |
Why?
|
Blood Patch, Epidural | 1 | 1998 | 57 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2001 | 646 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 677 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2001 | 618 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10776 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30230 | 0.010 |
Why?
|
Epidural Space | 1 | 1998 | 123 | 0.010 |
Why?
|
Paranasal Sinus Diseases | 1 | 1997 | 121 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2005 | 930 | 0.010 |
Why?
|
Pain | 2 | 2007 | 5102 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8072 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2007 | 2906 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1900 | 0.010 |
Why?
|
Schistosoma mansoni | 1 | 1997 | 156 | 0.010 |
Why?
|
Spinal Cord Neoplasms | 1 | 1998 | 263 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1996 | 348 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6277 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7458 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2004 | 1222 | 0.010 |
Why?
|
Water | 1 | 2001 | 1418 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4921 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2003 | 3553 | 0.010 |
Why?
|
Posture | 1 | 1998 | 956 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4785 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4859 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 1995 | 327 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 2693 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1996 | 1390 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8562 | 0.010 |
Why?
|
Kidney | 1 | 1967 | 7063 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1994 | 602 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1033 | 0.010 |
Why?
|
Drug Interactions | 1 | 1994 | 1420 | 0.010 |
Why?
|
Thymectomy | 1 | 1990 | 200 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1996 | 1424 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2001 | 3579 | 0.000 |
Why?
|
Parathyroid Hormone | 1 | 1995 | 1804 | 0.000 |
Why?
|
Cross-Over Studies | 1 | 1994 | 2106 | 0.000 |
Why?
|
Odds Ratio | 1 | 2000 | 9681 | 0.000 |
Why?
|
Disease | 1 | 1993 | 673 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 5044 | 0.000 |
Why?
|
Heart Diseases | 1 | 1999 | 2819 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1998 | 5311 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1966 | 19 | 0.000 |
Why?
|
Cleidocranial Dysplasia | 1 | 1966 | 18 | 0.000 |
Why?
|
Aortography | 1 | 1967 | 422 | 0.000 |
Why?
|
Fear | 1 | 1993 | 1494 | 0.000 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3609 | 0.000 |
Why?
|
Atrial Fibrillation | 1 | 2001 | 5168 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1993 | 2661 | 0.000 |
Why?
|
Proteins | 1 | 1995 | 6006 | 0.000 |
Why?
|
Chronic Disease | 1 | 1993 | 9380 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1967 | 2103 | 0.000 |
Why?
|